ConductScience.org, home

Paper72598

Surface antigenic characteristics of human glial brain tumor cells.

Wikstrand CJ and 2 others. Cancer Res, 1977. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Surface antigenic characteristics of human glial brain tumor cells. Papers, record 72598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/72598

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Surface antigenic characteristics of human glial brain tumor cells.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
1.72
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wikstrand CJC J
2Mahaley MSM S
3Bigner DDD D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Brain NeoplasmsMajor topic
GliomaMajor topic
Antibodies, Neoplasm
Antibody Specificity
Cell Line
Cell Membrane
Cytotoxicity Tests, Immunologic
Epitopes
Fluorescent Antibody Technique
HLA Antigens
Humans
Neoplasms, Experimental
Niacinamide

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
27310018BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.PLoS One2016https://conductscience.org/library/papers/27310018PubMed
19591631The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.Expert Opin Biol Ther2009https://conductscience.org/library/papers/19591631PubMed
18539480Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.Semin Immunol2008https://conductscience.org/library/papers/18539480PubMed
18363995Immunotherapy of malignant brain tumors.Immunol Rev2008https://conductscience.org/library/papers/18363995PubMed
11775071Establishment and partial characterization of a continuous human malignant glioma cell line: NG97.Cell Mol Neurobiol2001https://conductscience.org/library/papers/11775071PubMed
7211194Characterization of an established human malignant glioma cell line: LN-18.Acta Neuropathol1981https://conductscience.org/library/papers/7211194PubMed
7015802Immunohistochemical demonstration of IgG in meningioma.Acta Neurochir (Wien)1981https://conductscience.org/library/papers/7015802PubMed
6986786Immunobiologic aspects of the brain and human gliomas. A review.Am J Pathol1980https://conductscience.org/library/papers/6986786PubMed
6381659Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.J Neurooncol1984https://conductscience.org/library/papers/6381659PubMed
6090602Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.J Neurooncol1984https://conductscience.org/library/papers/6090602PubMed
3966985A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.Br J Cancer1985https://conductscience.org/library/papers/3966985PubMed
3890235The immunobiology of human gliomas.Springer Semin Immunopathol1985https://conductscience.org/library/papers/3890235PubMed
3494820Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor.J Neurooncol1987https://conductscience.org/library/papers/3494820PubMed
3279793Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.Am J Pathol1988https://conductscience.org/library/papers/3279793PubMed
3090477Immunobiology of brain tumors.Neurosurg Rev1986https://conductscience.org/library/papers/3090477PubMed
2660987Immunology of gliomas.Childs Nerv Syst1989https://conductscience.org/library/papers/2660987PubMed
2609939GD3 expression by cultured human tumor cells of neuroectodermal origin.Acta Neuropathol1989https://conductscience.org/library/papers/2609939PubMed
1659106Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.Acta Neuropathol1991https://conductscience.org/library/papers/1659106PubMed
518297Growth of measles virus in continuous cell lines derived from the nervous tissues of human and rat.Arch Virol1979https://conductscience.org/library/papers/518297PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/72598

GET https://conductscience.org/api/papers/v1/72598/authors